liposomal hpv-16 e6/e7 multipeptide vaccine pds0101
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Oct 14, 2020 (NCT04580771)
Timeline
Indications
Mechanism of action
- Human papillomavirusImmunity, active
Human papillomavirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05232851 | Phase 1/Phase 2 (Phase 2) | Mar 7, 2022 | Mayo Clinic, National Cancer Institute (NCI) |
| NCT04580771 | Phase 2 | Oct 14, 2020 | National Cancer Institute (NCI), University of Texas at Houston |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 2 | 0 | 1 | 2020 |
| Mayo Clinic | Academic/Hospital | 1 | 1 | 1 | 2022 |
| University of Texas at Houston | Academic/Hospital | 1 | 1 | 1 | 2020 |
3 organizations
Page 1 / 1